湖南医学
湖南醫學
호남의학
HUNAN MEDICAL JOURNAL
2001年
1期
13-14
,共2页
淋巴瘤,非霍奇金氏/治疗%鼻肿 瘤/治疗%鼻腔%回顾性研究
淋巴瘤,非霍奇金氏/治療%鼻腫 瘤/治療%鼻腔%迴顧性研究
림파류,비곽기금씨/치료%비종 류/치료%비강%회고성연구
目的对40例原发性鼻腔非霍奇金淋巴瘤(PNNHL)进行回顾性分析,以探讨其最佳治疗选择及其预后有关的因素。方法将40例患者分为单纯放疗,单纯化疗及综合治疗三组,对其1、3、5年生存率作相关比较。生存率用寿命表法统计,并作多因素卡方检验。结果通过5年生存率(SR5)比较结果表明,单纯放疗及综合治疗优于单纯化疗,临床Ⅰ、Ⅱ期的疗效优于Ⅲ、Ⅳ期。结论放射治疗是PNNHL治疗的最佳选择。临床分期早且无消瘦、发热、盗汗症状及采用放疗为主治疗是预后好的主要因素。
目的對40例原髮性鼻腔非霍奇金淋巴瘤(PNNHL)進行迴顧性分析,以探討其最佳治療選擇及其預後有關的因素。方法將40例患者分為單純放療,單純化療及綜閤治療三組,對其1、3、5年生存率作相關比較。生存率用壽命錶法統計,併作多因素卡方檢驗。結果通過5年生存率(SR5)比較結果錶明,單純放療及綜閤治療優于單純化療,臨床Ⅰ、Ⅱ期的療效優于Ⅲ、Ⅳ期。結論放射治療是PNNHL治療的最佳選擇。臨床分期早且無消瘦、髮熱、盜汗癥狀及採用放療為主治療是預後好的主要因素。
목적대40례원발성비강비곽기금림파류(PNNHL)진행회고성분석,이탐토기최가치료선택급기예후유관적인소。방법장40례환자분위단순방료,단순화료급종합치료삼조,대기1、3、5년생존솔작상관비교。생존솔용수명표법통계,병작다인소잡방검험。결과통과5년생존솔(SR5)비교결과표명,단순방료급종합치료우우단순화료,림상Ⅰ、Ⅱ기적료효우우Ⅲ、Ⅳ기。결론방사치료시PNNHL치료적최가선택。림상분기조차무소수、발열、도한증상급채용방료위주치료시예후호적주요인소。
Objective A retrospective analysis of forty cases with primarynasal non-Hodgkin lymphoma(PNNHL) was performed to investigate its optimal choice of treatment and prognosis-related factors.MethodsForty cases were divided into three groups--(1)Treated with radiotherapy alone;(2)treated with chemotherapy alone;and (3)treated by combined therapy. The clinical effects of three groups were compared each other using 1,3 and 5 year-survival rates. The survival rat e was statistically calculated by lifetable and multiple factor log-rank test . Results Having compared with the five-year survival rates(SR5),the therap eutic efficacy in first and third groups was better than that in second group; whereas that of patients in stage Ⅰ and Ⅱ was better than those in stage Ⅲ and Ⅳ. Conclusions The optimum choice of treatment for PNNHL is radiotherapy. The main favorite factors of prognosis could be the earlier clinical stage; without symptoms of emaciation, fever and night sweating; as well as adopting radiotherapy as the major measure of treatment.